No Data
No Data
No Data
No Data
No Data
An Intrinsic Calculation For Inari Medical, Inc. (NASDAQ:NARI) Suggests It's 29% Undervalued
Key Insights The projected fair value for Inari Medical is US$58.89 based on 2 Stage Free Cash Flow to Equity Inari Medical's US$41.60 share price signals that it might be 29% undervalued Our fair
Simply Wall StMay 2 19:22
Analysts Are Bullish on Top Healthcare Stocks: Qiagen (QGEN), Inari Medical (NARI)
TipRanksMay 2 14:45
Canadian Investment Banking Group: Maintaining the Inari Medical (NARI.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $75.00 to $55.00.
Canadian Investment Banking Group: Maintaining the Inari Medical (NARI.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $75.00 to $55.00.
Zhitong FinanceMay 2 03:00
Inari Medical Is Maintained at Overweight by Wells Fargo
Inari Medical Is Maintained at Overweight by Wells Fargo
Dow JonesMay 2 02:11
Wells Fargo Maintains Overweight on Inari Medical, Lowers Price Target to $84
Wells Fargo analyst Larry Biegelsen maintains Inari Medical with a Overweight and lowers the price target from $100 to $84.
Analyst UpgradesMay 2 02:01
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD) fell sharply during Wednesday's session as the company reported first-quarter results and issued revenue guidance for the second quarter.AMD guided
BenzingaMay 2 01:01
No Data
No Data